The company
Science Corporation.
Clinical-stage neural engineering company building BCI medical technologies.
NeurotechnologyBiotechMedical DevicesBrain-Computer InterfaceNeural Engineering
Company links
Company links
01 - Company overview
Science Corporation at a glance.
StageSeries C
SectorNeurotechnology, Biotech, Medical Devices, Brain-Computer Interface, Neural Engineering
LocationAlameda, CA
02 - The story
Clinical-stage neural engineering company building BCI medical technologies.
Science Corporation is a clinical-stage medical technology company building neural engineering products. Its PRIMA retinal implant program is designed to restore functional vision for patients with severe vision loss.
03 - Traction
What is working.
Signal 01$230M Series C announced in March 2026
Signal 02Approximately $490M total capital invested
Signal 03Backed by Khosla Ventures, Lightspeed, YC, IQT, and Quiet Capital
Signal 04Announced an oversubscribed $230 million Series C financing on March 5, 2026
Signal 05Reported approximately $490 million in total capital raised since founding in 2021
Signal 06Headquartered in Alameda, California.
Signal 07Reports dozens of patients enrolled across six countries in ongoing clinical studies.
Signal 08Announced a $230 million Series C financing on March 5, 2026.
Signal 09Says total capital invested since founding in 2021 is approximately $490 million.
Signal 10PRIMA is described by the company as its BCI retinal implant and expected commercial launch focus in Europe.
04 - Product
What you will see.
Product 01PRIMA retinal implant
Product 02Biohybrid neural interface
Product 03Science Foundry